BioSpace News Archive

Every week there are numerous scientific studies published. Here’s a look at some of the more interesting ones.

Numerous biopharmaceutical companies and researchers are presenting research and clinical trial results, and many have been announcing their plans for several weeks.

Biopharma and life sciences companies strengthen their leadership teams and boards with these Movers & Shakers.

In a paper published on Wednesday, Denali detailed the engineering of its transport vehicles.

The Texas Cardiac Arrhythmia at St. David’s Healthcare wants to ensure that our testing and treatment of patients is of the highest quality, and the health and safety of our employees and those who come to us for care is our primary concern.

National Health Foundation (NHF)

Johnson & Johnson (NYSE: JNJ) will participate in the Goldman Sachs 41st Annual Global Virtual Healthcare Conference on Tuesday, June 10. Jennifer Taubert, Executive Vice President, Worldwide Chairman Pharmaceuticals will represent the Company in a session scheduled at 11:20 a.m. (Eastern Time).

Part of the Foundation’s $100 million global COVID-19 relief initiative, grants focus on U.S. community response and health care in Europe and Africa.

MatriSys Bioscience, Inc., a leader in the field of microbiome-based therapeutics is pleased to announce that it was named a 2020 “Cool Company” by Connect/San Diego Venture Group (SDVG). Connect/SDVG is a regional, non-profit organization whose mission is to help innovators and entrepreneurs in Southern California by providing access to investors, mentors and education.

Mitsubishi Tanabe Pharma Canada, Inc., a subsidiary of Mitsubishi Tanabe Pharma America, Inc., announced that RADICAVA® is now listed on the Ontario Drug Benefit Formulary.